v3.26.1
Financial Instruments (Details) - USD ($)
$ / shares in Units, $ in Thousands
6 Months Ended
Dec. 31, 2024
Jun. 30, 2026
Dec. 31, 2025
Feb. 28, 2025
Jul. 22, 2024
May 31, 2022
Financial Instruments [Line Items]            
Warrant agreement amount           $ 180
Remeasured fair value   $ 390        
Consideration amount $ 6,000          
Common stock exercise price   $ 11.5        
2024 Convertible Notes [Member]            
Financial Instruments [Line Items]            
Additional aggregate amount         $ 2,600  
Reclassification to equity   $ 12,676        
Sponsor [Member]            
Financial Instruments [Line Items]            
Additional aggregate amount       $ 1,000    
Alpha Capital Anstalt [Member]            
Financial Instruments [Line Items]            
Additional aggregate amount         6,000  
Convertible Notes Payable [Member]            
Financial Instruments [Line Items]            
Initial Public Offering Scenario Probability     95.00%      
Merger and Acquisition Scenario Probability     5.00%      
Weighted Average Cost of Capital   25.00%        
Aggregate amount         $ 3,400  
Merger and Acquisition Scenario [Member]            
Financial Instruments [Line Items]            
Merger and Acquisition Scenario Probability     5.00%      
IPO [Member]            
Financial Instruments [Line Items]            
Initial Public Offering Scenario Probability     95.00%      
Weighted Average Cost of Capital     25.00%